# Evaluation of Gixam's Performance in a FIT Negative Population

Source: https://onco.cc/trials/nct06612281/  
OnCo record `nct06612281` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of colorectal cancer (CRC) screening in colorectal cancer, run by Jubaan Ltd., now recruiting.

## Summary

Evaluation of Gixam's Performance in a FIT Negative Population is a phase 2 interventional study registered as NCT06612281 by Jubaan Ltd., with 400 participants planned, started 2024-11-01 and due to reach its primary completion in 2025-03-30. Interventions recorded: colorectal cancer (CRC) screening and Colonoscopy after bowel cleansing.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06612281
- Phase: 2
- Setting: Evaluation of Gixam's Performance in a FIT Negative Population
- Sponsor: Jubaan Ltd.
- Enrolled: 400

## Sources

- ClinicalTrials.gov NCT06612281: https://clinicaltrials.gov/study/NCT06612281

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/)

---
JSON: https://onco.cc/api/v1/entities/nct06612281.json